动态动脉弹性与重症儿童流体反应的关联
Sarah B Walker1,2, Kyle S Honegger3,4, Michael S Carroll5
1Department of Pediatrics, Section of Critical Care, University of Colorado School of Medicine, Aurora, CO.
Critical care explorations
|July 14, 2025
概括
动态动脉弹性 (Eadyn) 没有预测低平均动脉压 (MAP) 的儿童的流体反应. 需要进一步的研究,以了解儿童心脏生理在休克更好的治疗策略.
科学领域:
- 儿科重症监护医药 儿科重症监护医药
- 心血管生理学心血管生理学
- 血液动力学监测 血液动力学监测
背景情况:
- 心脏机械效率预测了成年人的流体反应能力.
- 了解儿科流体反应能力对于管理休克至关重要.
研究的目的:
- 评估动态动脉弹性 (Eadyn) 与低平均动脉压 (MAP) 的儿童的流体反应 (FR) 之间的关联.
- 评估Eadyn是否可以预测儿科患者在液体玻尿酸后的MAP变化.
主要方法:
- 儿科重症监护室 (PICU) 患者的回顾性观察队列研究.
- 在18岁以下的儿童中分析了490个静脉晶体液球体 (≥10毫升/公斤).
- 埃迪恩计算的前流体玻尿酸;FR定义为≥10%的MAP增加后玻尿酸.
主要成果:
- 在MAP ≤50百分位的儿童中,Eadyn前与FR无关 (p > 0.1).
- 这种缺乏关联仍然存在于子组 (机械通风,血管活性药物).
- 大多数儿童表现出高机械效率 (Eadyn>0.7),即使MAP百分位数低.
结论:
- 动态动脉弹性似乎不是低MAP儿童流体反应的可靠预测指标.
- 需要进一步的研究来阐明在降低血压期间的儿科心脏生理学.
- 需要为儿童制定有针对性的,基于年龄的冲击管理策略.
相关概念视频
Blood Flow
Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
Regulation of Stroke Volume
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...


